[Form 4] Immix Biopharma, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Federal Realty Investment Trust (FRT) filed a Form 4 disclosing that CEO, President and Director Donald C. Wood transferred 33,857 common shares on 06/23/2025. The transaction is coded “G” (bona-fide gift), reflecting an estate-planning move rather than an open-market sale.

Wood moved the shares from his direct account to the Donald C. Wood Revocable Trust, of which he is sole trustee and beneficiary. Because he controls the trust, his economic ownership remains unchanged.

• Direct holdings after gift: 133,583 shares
• Indirect (trust) holdings after gift: 253,262 shares
• Total beneficial ownership: 386,845 shares

No derivative securities were involved and the filing does not signal any purchase or sale that would affect public float or cash proceeds. Investors typically view such intra-family or estate transfers as neutral events; they do not add selling pressure, nor do they generate insider buying signals. The filing was signed by attorney-in-fact Dawn M. Becker on 06/24/2025.

Positive

• Total insider ownership remains high (386,845 shares), indicating continued alignment with shareholders.

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Internal gift; ownership unchanged, no market impact.

This filing merely re-registers 33,857 shares under Donald Wood’s revocable trust. Such transfers are common for tax and succession planning. Wood’s combined stake of 386,845 shares—over 0.5% of outstanding shares—remains intact, preserving his alignment with shareholders. Because control is retained, neither voting power nor insider sentiment shifts. I view the disclosure as routine and non-material.

Portfolio Manager

TL;DR: Estate planning move; neutral for valuation.

The ‘G’ code indicates a gift at $0, so no proceeds were taken off the table. With no change in net position or cost basis, this action provides no actionable trading signal. Liquidity, leverage, and guidance metrics for FRT remain the primary drivers; this insider filing doesn’t alter the investment thesis. I classify the impact as neutral.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rachman Ilya M

(Last) (First) (Middle)

C/O IMMIX BIOPHARMA, INC.

11400 WEST OLYMPIC BLVD., SUITE 200

(Street)

LOS ANGELES CA 90064

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Immix Biopharma, Inc. [ IMMX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and Chairman

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/18/2025		P		2,178	A	$2.295(1)	1,138,437	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Volume-weighted average price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

	/s/ Ilya Rachman	06/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many FRT shares did CEO Donald C. Wood transfer in the Form 4?

He gifted 33,857 common shares to his revocable trust.

Was the transaction a sale or a gift?

It was recorded under code G (bona-fide gift); no shares were sold on the open market.

What is Donald Wood’s total beneficial ownership after the transaction?

He now beneficially owns 386,845 FRT shares (133,583 direct, 253,262 indirect).

Does this Form 4 filing affect the public float of FRT shares?

No. The shares remain under Wood’s control; therefore, public float and market supply are unchanged.

When was the Form 4 for Federal Realty Investment Trust filed?

The document was signed and filed on 06/24/2025.